Pulmonary vascular and cardiac impairment in interstitial lung disease
Pulmonary vascular and cardiac impairment is increasingly appreciated as a major adverse factor in the natural history of interstitial lung disease. This clinically orientated review focuses on the current concepts in the pathogenesis, pathophysiology and implications of the detrimental sequence of...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2017-01-01
|
Series: | European Respiratory Review |
Online Access: | http://err.ersjournals.com/content/26/143/160053.full |
id |
doaj-61fe918becb94c48ac5d0dd9d336ed83 |
---|---|
record_format |
Article |
spelling |
doaj-61fe918becb94c48ac5d0dd9d336ed832020-11-25T01:35:44ZengEuropean Respiratory SocietyEuropean Respiratory Review0905-91801600-06172017-01-012614310.1183/16000617.0053-20160053-2016Pulmonary vascular and cardiac impairment in interstitial lung diseaseMarios Panagiotou0Alistair C. Church1Martin K. Johnson2Andrew J. Peacock3 Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Glasgow, UK Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Glasgow, UK Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Glasgow, UK Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Glasgow, UK Pulmonary vascular and cardiac impairment is increasingly appreciated as a major adverse factor in the natural history of interstitial lung disease. This clinically orientated review focuses on the current concepts in the pathogenesis, pathophysiology and implications of the detrimental sequence of increased pulmonary vascular resistance, pre-capillary pulmonary hypertension and right heart failure in interstitial lung disease, and provides guidance on its management.http://err.ersjournals.com/content/26/143/160053.full |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Marios Panagiotou Alistair C. Church Martin K. Johnson Andrew J. Peacock |
spellingShingle |
Marios Panagiotou Alistair C. Church Martin K. Johnson Andrew J. Peacock Pulmonary vascular and cardiac impairment in interstitial lung disease European Respiratory Review |
author_facet |
Marios Panagiotou Alistair C. Church Martin K. Johnson Andrew J. Peacock |
author_sort |
Marios Panagiotou |
title |
Pulmonary vascular and cardiac impairment in interstitial lung disease |
title_short |
Pulmonary vascular and cardiac impairment in interstitial lung disease |
title_full |
Pulmonary vascular and cardiac impairment in interstitial lung disease |
title_fullStr |
Pulmonary vascular and cardiac impairment in interstitial lung disease |
title_full_unstemmed |
Pulmonary vascular and cardiac impairment in interstitial lung disease |
title_sort |
pulmonary vascular and cardiac impairment in interstitial lung disease |
publisher |
European Respiratory Society |
series |
European Respiratory Review |
issn |
0905-9180 1600-0617 |
publishDate |
2017-01-01 |
description |
Pulmonary vascular and cardiac impairment is increasingly appreciated as a major adverse factor in the natural history of interstitial lung disease. This clinically orientated review focuses on the current concepts in the pathogenesis, pathophysiology and implications of the detrimental sequence of increased pulmonary vascular resistance, pre-capillary pulmonary hypertension and right heart failure in interstitial lung disease, and provides guidance on its management. |
url |
http://err.ersjournals.com/content/26/143/160053.full |
work_keys_str_mv |
AT mariospanagiotou pulmonaryvascularandcardiacimpairmentininterstitiallungdisease AT alistaircchurch pulmonaryvascularandcardiacimpairmentininterstitiallungdisease AT martinkjohnson pulmonaryvascularandcardiacimpairmentininterstitiallungdisease AT andrewjpeacock pulmonaryvascularandcardiacimpairmentininterstitiallungdisease |
_version_ |
1725066706992234496 |